SYS-CON MEDIA Authors: Elizabeth White, Doug Masi, Mat Mathews, PR.com Newswire, David Smith

News Feed Item

Imprivata to Release Q2 2014 Financial Results on August 4, 2014

Imprivata® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that the company will release the results for its second quarter ended June 30, 2014 after the market closes on Monday, August 4, 2014. Imprivata will hold a conference call for investors on August 4 at 5:00 p.m. EDT during which management will review highlights from the company's second quarter 2014 results, its business outlook and other matters.

The call can be accessed by dialing 877-270-2148 or 412-902-6510 for international callers, and referencing “Imprivata 2nd Quarter”.

An audio webcast of the call will be available live and archived on Imprivata’s investor relations website at http://investor.imprivata.com.

A replay of the conference call will be available approximately one hour after conclusion of the call and will be accessible through August 18, 2014. The replay can be accessed by dialing 877-344-7529, or 412-317-0088 for international callers, and providing access code 10049678.

About Imprivata

Imprivata is a leading provider of authentication and access management solutions for the healthcare industry. Imprivata’s single sign-on, authentication management and secure communications solutions enable fast, secure and more efficient access to healthcare information technology systems to address multiple security challenges and improve provider productivity for better focus on patient care. For more information, please visit www.imprivata.com.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.